Keyword: GlaxoSmithKline (GSK)

News

GlaxoSmithKline Offer lifts Indian Stakeholding to 75%

12.03.2014 - British drugmaker GlaxoSmithKline (GSK) said it has successfully increased its stake in its publicly-listed Indian pharmaceuticals subsidiary GlaxoSmithKline Pharmaceuticals...

News

Bayer, Novartis said to Eye Merck & Co consumer health unit

21.02.2014 - A handful of consumer and healthcare companies including Germany's Bayer and Switzerland's Novartis are exploring a deal for Merck & Co's consumer healthcare business, people...

News

Facing Fines, Glaxo SmithKline to Stop Drug Promotion Excesses

19.12.2013 - UK drugmaker Glaxo SmithKline has said it would cease offering financial incentives to doctors to promote its products through speaking engagements, for example. The company also...

News

Cameron Raises GSK’s Problems as CEO Joins Him On China Visit

03.12.2013 - British Prime Minister David Cameron raised GlaxoSmithKline's problems in China - where it is being investigated for alleged bribery - with political leaders on Monday as the...

News

Glaxo SmithKline to Invest in Scottish Plant expansion

27.11.2013 - Glaxo SmithKline (GSK) has announced plans to invest £25 million in expanding its active ingredient formulating plant at Montrose, Scotland. The UK drug maker said it would locate...

News

GlaxoSmithKline India Hit By Drop In Bulk Orders

08.10.2013 - GlaxoSmithKline's Indian business has been hit by a drop in sales which two industry sources said was linked to a protest by bulk buyers against a cut in their profit margins under...

News

Astrazeneca CEO Gets Two Cheers after First Year in Job

01.10.2013 - Fixing ailing drugmaker AstraZeneca remains a work in progress for Chief Executive Pascal Soriot, with sales and profits still heading firmly downhill after his first year in the...

News

AstraZeneca Looks for New Heart Drug Approval by Next May

19.09.2013 - U.S. regulators have accepted an experimental fish oil-based heart drug from AstraZeneca for review and will make a decision on whether to approve it by next May. Epanova, for...